http://www.krystalbio.com
Krystal Biotech, Inc. Company Intro
Dystrophic Epidermolysis BullosaB-VECREAD MORETGM1-deficient ARCIKB105READ MOREJunctional Epidermolysis BullosaKB107READ MORENetherton SyndromeKB104READ MOREAdditional Dermatological IndicationsOur TherapiesREAD MORE Vision We strive to be the leader in the development of novel and effective "off-the-shelf" gene therapy products to fight some of the world's most serious skin diseases Mission To develop transformative, innovative, and science-based viral gene therapy products and […]
Industry
Healthcare
Krystal Biotech, Inc. Headquaters
2100 Wharton Street
Pittsburgh,15203
United States
Krystal Biotech, Inc. Share price
17 May 2023 13:26 GMT
$88.79
-1.26 (-1.4 %)
Krystal Biotech, Inc. Market cap
$2.335 B
WMC RANKING
2024
Krystal Biotech, Inc. # 381
BiotechnologyLatest Krystal Biotech, Inc. News
12 Feb 2024
Lost in translation? Improving the commercial success of Pittsburgh's life sciences ecosystem
Boosting the region's biotech sector requires a rethink of talent, education, and access to smart capital, this startup mentor...
12 Feb 2024
Lost in translation? Improving the commercial success of Pittsburgh's life sciences ecosystem
Boosting the region's biotech sector requires a rethink of talent, education, and access to smart capital, this startup mentor writes.
12 Feb 2024
Lost in translation? Improving the commercial success of Pittsburgh's life sciences ecosystem
Boosting the region's biotech sector requires a rethink of talent, education, and access to smart capital, this startup mentor writes.
WMC Market Score
WMC Market to Revenue Score
Krystal Biotech, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Krystal Biotech, Inc. | USD | $0 | $41,406 | $-42,638 | $23,350B | 381 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Krystal Biotech, Inc. Social Followers vs Top 4 Industry Competitors
Krystal Biotech, Inc. Post vs Top 4 Industry Competitors
Krystal Biotech, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Krystal Biotech, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Krystal Biotech, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Krystal Biotech, Inc. | 0 | 2.53 | 0.04 | 0 | 0 | 0 | 0.91 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
